HLS Therapeutics Inc.

HLS.TOTSXHealthcare● Active

$4.41

$-0.06(-1.34%)

Market Cap$137917017

P/E Ratio—

52W High$5.765

52W Low$0.001

Avg Volume7K

Open$4.40

Beta0.85

Cash on Hand Financials Revenue

HLS Therapeutics Inc. (HLS.TO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

HLS.TO · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$11.7M▼ -33.0% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$11.7M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-33.0%

vs prior fiscal year

Latest Quarter

$12.3M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$11.7MCash on Hand

Total Debt$49.7MTotal Debt

Net Cash / Net Debt−$38.0MNet Debt Position

Cash vs Debt Ratio

Cash 19%HLS Therapeutics Inc. cash as % of market cap: 8.48%% · MCap $0BDebt 81%

HLS Therapeutics Inc. carries a net debt position of $38.0M. Total debt ($49.7M) exceeds cash on hand ($11.7M). HLS Therapeutics Inc. cash vs debt ratio: 19% cash / 81% debt.

Net Cash = Cash & ST Investments − Total Debt$11.7M − $49.7M = −$38.0M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

HLS.TO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

HLS.TO cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$11.7M-33.0%

Dec 31, 2024FY$17.5M-20.5%

Dec 31, 2023FY$22.0M+5.9%

Dec 31, 2022FY$20.7M-2.2%

Dec 31, 2021FY$21.2M+2.8%

HLS.TO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

HLS.TO vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

HLS Therapeutics Inc.YOU

HLS.TO

$11.7M$138M8.5%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

HLS Therapeutics Inc. (HLS.TO) cash on hand as of December 31, 2025 is $11.7M, comprising $11.7M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as HLS Therapeutics Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as HLS Therapeutics Inc. cash reserves or cash position.

HLS Therapeutics Inc. annual cash on hand history shows decreased -33.0% in 2025: decreased -33.0% in 2025. HLS Therapeutics Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

HLS Therapeutics Inc. carries total debt of $49.7M against cash of $11.7M, resulting in a net debt position of -$38.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

HLS.TO cash on hand · 5 questions

As of December 31, 2025, HLS Therapeutics Inc. (HLS.TO) has $11,701,665 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $11,701,665 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $12,334,714. Data sourced from the annual 10-K filing via FMP.

HLS.TO cash on handHLS.TO cash reservesHLS.TO cash 2025how much cash does HLS.TO have

▸ Source: FMP /balance-sheet-statement · US GAAP · HLS Therapeutics Inc. · HLS Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025